Circular RNAs as novel potential biomarkers for pancreatic cancer

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Pancreatic cancer (PaCa) is the fourth leading cause of cancer-related deaths in the United States, and the vast majority of these malignancies are pancreatic ductal adenocarcinomas (PDAC), but there is still a lack of early detection biomarkers for PaCa. Unlike linear RNAs, circRNAs form covalently closed continuous loops and can act as mammalian gene regulators. They may be diagnostic or predictive biomarkers for some tumors, also be novel potential therapeutic targets in different diseases. This review focuses on (1) the biogenesis of circRNAs, RNA binding proteins (RBPs) and complementary sequences of circRNAs; (2) the characteristics of circRNAs which allow them to interact with miRNAs; (3) the roles of circRNAs playing in the regulation of gene expression, cell behavior and cancer, and their potential role as novel biomarkers and therapeutic targets in pancreatic cancer.

Cite

CITATION STYLE

APA

Liu, S., Li, Q., Ma, Y., Corpe, C., & Wang, J. (2021). Circular RNAs as novel potential biomarkers for pancreatic cancer. Journal of Cancer. Ivyspring International Publisher. https://doi.org/10.7150/JCA.58640

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free